Modiquest B.V.
Records under this name other than the patents Modiquest B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 8 of 8 · Back to Modiquest B.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,703,822 | Anti-inflammatory agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,718,877 | Anti-inflammatory agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,233,236 | A Method of Treating or Preventing Rheumatoid Arthritis Formerly held In force · Low confidence | In force | Low confidence | |
| US RE46,990 | Anti-inflammatory agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,066,462 | Method for the Treatment of Idiopathic Pulmonary Fibrosis Formerly held In force · High confidence | In force | High confidence | |
| US 9,422,358 | Plexin D1 as a target for tumor diagnosis and therapy Lapsed on the fee record Ended Aug 23, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 23, 2024 | From the USPTO record |
| US 9,109,019 | Anti-inflammatory agents Formerly held Surrendered on reissue Surrendered on reissue Aug 14, 2018 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Aug 14, 2018 | From the USPTO record |
| US 8,404,647 | Peptidylarginine Deiminase (PAD) Inhibitors Formerly held Lapsed on the fee record Ended Mar 26, 2017 · High confidence | Lapsed on the fee record | Ended Mar 26, 2017 | High confidence |